在动脉样硬化中,FOXO1集成了内皮血液动力学,炎症和代谢途径
Hanqiang Deng1,2, Xing Zhang1, Yewei Wang3
1Yale Cardiovascular Research Center (H.D., X.Z., D.J., M.A.S.), Yale University School of Medicine, New Haven, CT.
Circulation research
|February 25, 2026
概括
叉头盒蛋白O1 (FOXO1) 通过乳化将受损的血流与内皮炎症和动脉样硬化联系在一起. 生理流抑制FOXO1,这表明心血管疾病的新治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 内皮细胞生物学 内皮细胞生物学
- 动脉样硬化的分子机制
背景情况:
- 动脉样硬化最好发生在流体剪切应力 (FSS) 受到干扰的区域,而层状FSS是保护性的.
- 内皮炎症与糖解有关,与抗炎性氧化酸化形成鲜明对比,但机制尚不清楚.
- 转录因子FOXO1调节内皮代谢和血管生成,但其在炎症中的作用尚不清楚.
研究的目的:
- 研究FOXO1在内皮炎症中的作用及其通过流体剪切应力调节的作用.
- 阐明FOXO1影响动脉样硬化发展的分子机制.
- 为了确定动脉样硬化心血管疾病的潜在治疗点.
主要方法:
- 内皮细胞在体外暴露于细胞因子或定义的流动模式.
- 检测包括免疫光,RNA测序和生物化学分析,以评估FOXO1.1.
- 在体内研究中使用了内皮细胞特异性FOXO1淘汰赛小鼠和诱导的高脂血症来模拟动脉样硬化.
主要成果:
- 扰乱的FSS和细胞因子促进FOXO1核转位,而生理FSS则抑制了它.
- FOXO1 枯竭调高了保护性转录因子 (KLF2/4) 和降低了炎症基因表达.
- 生理学FSS通过KLF2-CDK2信号抑制了FOXO1;乳酸盐通过乳化促进了FOXO1核定位.
- 在小鼠中,内皮细胞特异性FOXO1删除显著减少了动脉样硬化斑块.
结论:
- FOXO1作为一个关键的调解者,通过乳酸驱动的乳酸和核转位,将阿瑟罗流与内皮炎症联系起来.
- 生理学FSS通过KLF2-CDK2信号抑制FOXO1活动,提供一个反调节机制.
- 这些发现突出了FOXO1及其调节途径作为动脉样硬化心血管疾病的潜在治疗点.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Regulation of the Cardiovascular System
4.4K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.4K
Nitric Oxide Signaling Pathway
6.4K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.4K
Extrinsic and Intrinsic Pathways of Hemostasis
14.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.0K
Mechanism of Angiogenesis
7.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.2K
Coronary Artery Disease II: Pathophysiology
805
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
805


